Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.
Engage Bio transforms cells into factories for therapeutic proteins, revolutionizing cancer treatment with non-viral gene therapies.
Contact Engage Bio for detailed pricing information tailored to your specific needs and use cases.
Engage Bio is actively hiring to build the next generation of cancer therapy. Join us to work on cutting-edge treatments and make a significant impact in the field of biotechnology. Explore open positions and become part of our innovative team.
Kernal is creating mRNA 2.0 therapies that work in specific cells
Engineering cells to unlock the next generation of mRNA medicines
Dendritic cell-based platform for cancer therapy
Next-generation mRNA medicines
Adventris makes cancer vaccines
We build better immunotherapies
Combining 3D cell culture & AI to translate drugs to clinical success
Cancer targeting attack particles
Personalized drug discovery for blood cancer.
Viral immunotherapies that turn cancer cells into biofactories
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS